2026 Executive War College Agenda
As session topics and speakers are confirmed, they will be posted on this page.
Watch this site regularly to catch all the new topics and speakers.
You can save $200 off the full price of a 2026 seat
by Registering today or by February 14, 2026.
We look forward to seeing you in New Orleans!
Agenda development is well underway for EWC 2026, where we anticipate featuring almost 150 sessions and 90 speakers.
As of this stage, here’s a look at the sessions and speakers we have planned so far. Check back frequently, since our agenda will continue to grow in the coming weeks. Specific days, times, and locations for each session will be announced in the future.
SESSION
Schedule TBD
Under OIG Scrutiny: Translating 2025 Enforcement Trends Into Actionable Strategies for Laboratory Compliance, Test Utilization Optimization, and Enterprise-Wide Risk Mitigation in 2026
Andrew Fletcher
Founder,
Eutilogic
Danielle Tangorre
Partner,
Robinson & Cole
SESSION
Schedule TBD
Transforming Pathology at Scale: NYU Langone’s Achievement of a Fully Digital Workflow in One Year to Accelerate Diagnosis, Collaboration, and AI-Enabled Innovation
Christina Olesnycky
Senior Administrative Director of Laboratory Services,
NYU Langone Health
Syed T. Hoda, MD
Director of Digital Pathology, Director of Bone & Soft Tissue Pathology, Clinical Professor,
NYU Langone Health
SESSION
Schedule TBD
The Slippery Slope to Enforcement: How Payor Audits Trigger Government Action—and How to Identify Compliance Risk Early
Edward Heath
Chair,
Robinson & Cole
Seth Orkand
Partner,
Robinson & Cole
Danielle Tangorre
Partner,
Robinson & Cole
SESSION
Schedule TBD
Recognizing Laboratory Leadership and Excellence: A Designation Program That Elevates Patient Care, Professional Development, and the Field of Laboratory Medicine
Alexandra Brown
Interim CEO,
ASCP
SESSION
Schedule TBD
Transforming Revenue Cycle Management with Agentic AI: A New Model for Laboratory Reimbursement That Optimizes Decision-Making and Drives Higher Financial Performance
Ellen Beausang
President, CRO
Lighthouse Laboratories
Jeff Carmichael
Senior VP of Engineering,
XiFin, Inc.
Heather Agostinelli
VP, Head of Strategic Revenue Operations,
XiFin, Inc.
SESSION
Schedule TBD
Laboratory Outreach Program Dynamics: Where Are You Now, What Challenges Are Holding You Back, and What Do You Need to Be Doing to Advance Your Program, Expand Outreach, and Strengthen System-Wide Impact?
Jane Hermansen
Manager, Outreach and Network Development,
Mayo Clinic
SESSION
Schedule TBD
The Hidden Profit Center: Stop Leaving Money on the Table by Leveraging Laboratory Operations and Excess Capacity for Enterprise-Wide Financial Results
Jonathan Burgart
Director US Marketing,
Abbott
SESSION
Schedule TBD
Bridging Bench and Bytes: Practical Strategies, Core Concepts, and Real-World Case Studies in Software Implementation for the Non-IT Laboratorian
Josh Kramer
Founder, Managing Partner,
Leap Consulting Group
SESSION
Schedule TBD
Transforming Laboratory Revenue Integrity: Standardizing Charge Reconciliation to Strengthen Financial Performance and Enterprise Data Quality
Lauren McDonald
Senior Beaker Consultant,
Honeydew Consulting
Shelly Barnes
Lab Billing Supervisor,
Spartanburg Regional Healthcare System
SESSION
Schedule TBD
From Open Scopes to Fully Staffed Positions: Winning Data-Driven Pathology Recruiting Strategies in a Highly Competitive, Candidate-Driven Market
Rich Cornell
Owner,
Sante Consulting
SESSION
Schedule TBD
Breaking the Traveler Cycle: How to Replicate Proven, High-Impact Workforce Strategies to Achieve Sustainable, Long-Term Laboratory Staffing and Operational Stability
Stefanie Davidson
Laboratory Director,
Foundation Health
SESSION
Schedule TBD
The 3 P’s Powering a Resilient and High Performance Lab Workforce that drives Quality and Reduces Cost
Walter McAndrew,
MB(ASCP), SSGB
Molecular Diagnostics Laboratory Manager,
MD Anderson
SESSION
Schedule TBD
Succession Planning: Strategies to Identify, Develop, and Retain High-Potential Talent, Build a Resilient Leadership Pipeline, and Safeguard Long-Term Stability for Your Future Organizational Success
Curtiss McNair
VP Operations,
PanGIA Biotech
SESSION
Schedule TBD
Beyond the Transition: Leveraging Analytical Tools to Preserve Laboratory Performance, Optimize Operations, and Ensure Success During LIS Migration
Kathleen T. Ohrt
Program Manager,
Visiun, Inc.
Marieke de Klerk
Business Operations Reporting Analyst,
Ochsner Medical Center
SESSION
Schedule TBD
2026 Payor Denial Impact Report: Unveiling the Latest Trends and Recommended Practices for Optimizing Clinical Lab, Hospital Outreach, Molecular and Pathology Claim Denials and Appeals
Diana Richard
AVP, National Accounts,
Xfin, Inc.
Stephanie Denham
VP, RCM Systems and Analytics,
Xfin, Inc.
SESSION
Schedule TBD
Maximizing Value in Digital Pathology: A Comprehensive ROI Analysis of Whole‑Slide Image Optimization to Reduce Costs, Accelerate Diagnostics, and Support Scalable Adoption
David Braxton, MD
Chief of Molecular Pathology,
Hoag Hospital
Mark Lloyd
VP of Pathology,
FujiFilm
SESSION
Schedule TBD
Zero-Failure E-Orders: Sentara’s Blueprint for Closing the EMR-to-LIS Loop to Guarantee Lab Revenue and Operational Accuracy
Kristen Keenan
Senior Director,
Laboratory Services-Outreach,
Sentara Health
Rebecca Larkins
Director, Client Relations
4Medica
SESSION
Schedule TBD
Unlocking the Value of Excess Lab Capacity: Generate Net New Revenue While Reducing Patient Costs and Reinforcing Local Healthcare Access
Ashley Rene
Consultant,
Collaboratory
Ronald Sparks
Executive Director,
Collaboratory
SESSION
Schedule TBD
Integrating AI in Pathology: Real-World Strategies for Balancing Regulatory Authorization and Reimbursement Challenges in Laboratory-Developed Tests and Software as a Medical Device
Amanda Lowe
Chief Commercial Officer,
Artera
Jennifer Archer
Senior Director Market Access
Artera
SESSION
Schedule TBD
Panel — From Policy to Practice: Navigating Biomarker Legislation, Translating Regulatory Change into Laboratory Strategy, and Leveraging Precision Diagnostics to Drive Sustainable Growth and Enterprise Impact
Michael Ryan
Partner,
McDermott Will & Emery LLP
Robin Harper Cowie
Chief Financial Officer,
Biodesix
Derek Maetzold
Founder, President & CEO,
Castle Biosciences
Noreen Manning
Vice President, Reimbursement,
Castle Biosciences
SESSION
Schedule TBD
Building Trust in AI Adoption for Pathology: A CAP AI Studio Immersive, Hands-On Experience Exploring Validated AI Tools in Real-World Clinical Scenarios
Rajendra Singh, MD
Professor of Pathology,
University of Pennsylvania
Co-Founder,
PathPresenter
Kevin Schap
Director, Clinical Informatics Initiatives,
College of American Pathologists (CAP)
Special Learning Opportunities
Choose From These
Exceptional Sessions
Day 3 Sessions
Thursday, April 30, 2026
SESSION 1
8:30 AM - 3:00 PM
Executive Forum on Digital Pathology Management
SESSION 2
8:30 AM - 3:00 PM
Lean Six Sigma For Lab Leaders